Glenmark Pharma: A Healthy Dose Of Growth

Glenmark Pharma: A Healthy Dose Of Growth Glenmark, which has graduated to a global organisation in a very short span with its expanded manufacturing footprint, international operations and global employee base, reported a 276.08 per cent rise in revenue since 2012 The company that emerged as India’s third fastest growing company in the Rs 5,000 crore to Rs 9,999 crore turnover category in BW Businessworld’s Fastest Growing Companies list 2017, says its strategic roadmap is completely synergised with its business, and its aim is to move up the value chain to become an innovation-led company with a solid foundation in Read More


Glenmark set to seek FDA nod for new nasal spray in FY18

Glenmark set to seek FDA nod for new nasal spray in FY18 Glenmark Pharmaceuticals announces positive results from phase-III clinical trials conducted in the US for the nasal spray Mumbai: Glenmark Pharmaceuticals Ltd will file a new drug application with the US drugs regulator for its nasal spray to treat seasonal allergic rhinitis—commonly known as hay fever—in the year starting 1 April, chairman and managing director Glenn Saldanha said. The Mumbai-based pharma major on Thursday announced positive results from phase-III clinical trials conducted in the US for the nasal spray containing a fixed-dose combination of 25 mcg mometasone furoate and Read More


Positive phase 3 data on GSP 301; USD 100m opportunity for co: Glenmark

Positive phase 3 data on GSP 301; USD 100m opportunity for co: Glenmark Glenmark Pharma reports positive results from a phase 3 trial of GSP 301, a fixed-dose combination nasal spray. Glenmark Pharma reports positive results from a phase 3 trial of GSP 301, a fixed-dose combination nasal spray. In an interview to CNBC-TV18, Glenn Saldanha, CMD of Glenmark Pharma spoke about GSP 301 and other branded products under development. Below is the verbatim transcript of the interview. Anuj: Can we expect an out licensing deal on this and how big is this going to be for Glenmark. Could you Read More


Lowering tax on MSME’s is a welcome step: Glenn Saldanha, Glenmark Pharmaceuticals

Lowering tax on MSME’s is a welcome step: Glenn Saldanha, Glenmark Pharmaceuticals Government has shown its clear intent towards fast-tracking inflow of FDI, and the scrapping of FIPB is a notable step. Overall, the Union Budget2017 is a step in the right direction. While it has focused on economic reforms and liberalisation of the economy, it has also allocated funds to bring more irrigation, roads, electricity and sanitation to rural India. Even though the economic survey paints a sober picture for FY16-17 primarily due to a weaker second half, the budget provides the necessary impetus to sustain GDP growth at Read More


ˆ Back To Top